Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

por Mohan, Riche, Kneebone, A., Eade, T., Hsiao, E., Emmett, L., Brown, Christopher, Hunter, J., Hruby, G.
Publicado 2023

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pa...

por Goldstein, D, Spry, N, Cummins, M M, Brown, C, van Hazel, G A, Carroll, S, Selva-Nayagam, S, Borg, M, Ackland, S P, Wratten, C, Shapiro, J, Porter, I W T, Hruby, G, Horvath, L, Bydder, S, Underhill, C, Harvey, J, Gebski, V J
Publicado 2012